119 related articles for article (PubMed ID: 14613643)
21. Expression of emmprin (CD147), a cell surface inducer of matrix metalloproteinases, in normal human brain and gliomas.
Sameshima T; Nabeshima K; Toole BP; Yokogami K; Okada Y; Goya T; Koono M; Wakisaka S
Int J Cancer; 2000 Oct; 88(1):21-7. PubMed ID: 10962435
[TBL] [Abstract][Full Text] [Related]
22. Association of extracellular matrix metalloproteinase inducer in endometrial carcinoma with patient outcomes and clinicopathogenesis using monoclonal antibody 12C3.
Ueda K; Yamada K; Urashima M; Ishibashi Y; Shirai M; Nikaido T; Takahashi H; Okamoto A; Saito M; Yasuda M; Ohkawa K; Tanaka T
Oncol Rep; 2007 Apr; 17(4):731-5. PubMed ID: 17342307
[TBL] [Abstract][Full Text] [Related]
23. Expression of EMMPRIN in adenoid cystic carcinoma of salivary glands: correlation with tumor progression and patients' prognosis.
Yang X; Dai J; Li T; Zhang P; Ma Q; Li Y; Zhou J; Lei D
Oral Oncol; 2010 Oct; 46(10):755-60. PubMed ID: 20850374
[TBL] [Abstract][Full Text] [Related]
24. Correlation between expression of extracellular matrix metalloproteinase inducer and matrix metalloproteinase-2 and cervical lymph node metastasis of nasopharyngeal carcinoma.
Huang T; Chen MH; Wu MY; Wu XY
Ann Otol Rhinol Laryngol; 2013 Mar; 122(3):210-5. PubMed ID: 23577575
[TBL] [Abstract][Full Text] [Related]
25. Increased expression of extracellular matrix metalloproteinase inducer is associated with matrix metalloproteinase-1 and -2 in gingival tissues from patients with periodontitis.
Dong W; Xiang J; Li C; Cao Z; Huang Z
J Periodontal Res; 2009 Feb; 44(1):125-32. PubMed ID: 19515022
[TBL] [Abstract][Full Text] [Related]
26. Characterization of 3 oral squamous cell carcinoma cell lines with different invasion and/or metastatic potentials.
Erdem NF; Carlson ER; Gerard DA; Ichiki AT
J Oral Maxillofac Surg; 2007 Sep; 65(9):1725-33. PubMed ID: 17719389
[TBL] [Abstract][Full Text] [Related]
27. Upstream regulation of matrix metalloproteinase by EMMPRIN; extracellular matrix metalloproteinase inducer in advanced atherosclerotic plaque.
Yoon YW; Kwon HM; Hwang KC; Choi EY; Hong BK; Kim D; Kim HS; Cho SH; Song KS; Sangiorgi G
Atherosclerosis; 2005 May; 180(1):37-44. PubMed ID: 15823273
[TBL] [Abstract][Full Text] [Related]
28. The microvesicle as a vehicle for EMMPRIN in tumor-stromal interactions.
Sidhu SS; Mengistab AT; Tauscher AN; LaVail J; Basbaum C
Oncogene; 2004 Jan; 23(4):956-63. PubMed ID: 14749763
[TBL] [Abstract][Full Text] [Related]
29. High extracellular matrix metalloproteinase inducer/CD147 expression is strongly and independently associated with poor prognosis in colorectal cancer.
Stenzinger A; Wittschieber D; von Winterfeld M; Goeppert B; Kamphues C; Weichert W; Dietel M; Rabien A; Klauschen F
Hum Pathol; 2012 Sep; 43(9):1471-81. PubMed ID: 22417846
[TBL] [Abstract][Full Text] [Related]
30. Expression of extracellular matrix metalloproteinase inducer in human placenta and fetal membranes at term labor.
Li W; Alfaidy N; Challis JR
J Clin Endocrinol Metab; 2004 Jun; 89(6):2897-904. PubMed ID: 15181074
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of extracellular matrix metalloproteinase inducer in multidrug resistant cancer cells.
Yang JM; Xu Z; Wu H; Zhu H; Wu X; Hait WN
Mol Cancer Res; 2003 Apr; 1(6):420-7. PubMed ID: 12692261
[TBL] [Abstract][Full Text] [Related]
32. Tumorigenic potential of extracellular matrix metalloproteinase inducer.
Zucker S; Hymowitz M; Rollo EE; Mann R; Conner CE; Cao J; Foda HD; Tompkins DC; Toole BP
Am J Pathol; 2001 Jun; 158(6):1921-8. PubMed ID: 11395366
[TBL] [Abstract][Full Text] [Related]
33. Extracellular matrix metalloproteinase inducer expression in salivary gland tumors: a correlation with microvessel density.
Huang ZQ; Chen WL; Li HG; Li JS; Xu ZY; Lin ZY
J Craniofac Surg; 2010 Nov; 21(6):1855-60. PubMed ID: 21119439
[TBL] [Abstract][Full Text] [Related]
34. Upregulation of extracellular matrix metalloproteinase inducer (EMMPRIN) and gelatinases in human atherosclerosis infected with Chlamydia pneumoniae: the potential role of Chlamydia pneumoniae infection in the progression of atherosclerosis.
Choi EY; Kim D; Hong BK; Kwon HM; Song YG; Byun KH; Park HY; Whang KC; Kim HS
Exp Mol Med; 2002 Dec; 34(6):391-400. PubMed ID: 12526080
[TBL] [Abstract][Full Text] [Related]
35. EMMPRIN (CD147), an inducer of matrix metalloproteinase synthesis, also binds interstitial collagenase to the tumor cell surface.
Guo H; Li R; Zucker S; Toole BP
Cancer Res; 2000 Feb; 60(4):888-91. PubMed ID: 10706100
[TBL] [Abstract][Full Text] [Related]
36. Expression of extracellular matrix metalloproteinase inducer and enhancement of the production of matrix metalloproteinase-1 in tongue squamous cell carcinoma.
Cao Z; Xiang J; Li C
Int J Oral Maxillofac Surg; 2009 Aug; 38(8):880-5. PubMed ID: 19372030
[TBL] [Abstract][Full Text] [Related]
37. E-cadherin immunostaining of bladder transitional cell carcinoma, carcinoma in situ and lymph node metastases with long-term followup.
Byrne RR; Shariat SF; Brown R; Kattan MW; Morton RA JR; Wheeler TM; Lerner SP
J Urol; 2001 May; 165(5):1473-9. PubMed ID: 11342899
[TBL] [Abstract][Full Text] [Related]
38. EMMPRIN expression as a prognostic factor in radiotherapy of cervical cancer.
Ju XZ; Yang JM; Zhou XY; Li ZT; Wu XH
Clin Cancer Res; 2008 Jan; 14(2):494-501. PubMed ID: 18223224
[TBL] [Abstract][Full Text] [Related]
39. Extracellular matrix metalloproteinase inducer expression has an impact on survival in human bladder cancer.
Zhong WD; Chen QB; Ye YK; Han ZD; Bi XC; Dai QS; Liang YX; Zeng GH; Wang YS; Zhu G; Chen ZN; He HC
Cancer Epidemiol; 2010 Aug; 34(4):478-82. PubMed ID: 20483678
[TBL] [Abstract][Full Text] [Related]
40. [Expressions of CD147 and matrix metalloproteinase-2 in breast cancer and their correlations to prognosis].
Zhou S; Liu C; Wu SM; Wu RL
Ai Zheng; 2005 Jul; 24(7):874-9. PubMed ID: 16004819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]